loadpatents
name:-0.050817966461182
name:-0.013889074325562
name:-0.0012140274047852
Rosenberger; Vered Patent Filings

Rosenberger; Vered

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rosenberger; Vered.The latest application filed is for "stable topical compositions of fenoldopam".

Company Profile
1.11.44
  • Rosenberger; Vered - Givatayim IL
  • Rosenberger; Vered - Jerusalem IL
  • Rosenberger; Vered - Modiin IL
  • Rosenberger; Vered - Moddiin IL
  • Rosenberger; Vered - Mudiin IL
  • Rosenberger, Vered - Givat Masuah Jerusalem IL
  • Rosenberger, Vered - Givataim IL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Stable topical compositions of fenoldopam
Grant 11,446,237 - Shifrin , et al. September 20, 2
2022-09-20
Stable Topical Compositions Of Fenoldopam
App 20220040089 - SHIFRIN; Helena ;   et al.
2022-02-10
Topical Montelukast Formulations
App 20220016028 - ROSENBERGER; Vered ;   et al.
2022-01-20
Topical Montelukast Formulations
App 20210393613 - ROSENBERGER; Vered ;   et al.
2021-12-23
Topical Montelukast formulations
Grant 11,173,117 - Rosenberger , et al. November 16, 2
2021-11-16
Topical Montelukast Formulations
App 20210236423 - ROSENBERGER; Vered ;   et al.
2021-08-05
Topical Montelukast For Treatment Of Atopic Dermatitis
App 20200237651 - AVRAMOFF; Avi ;   et al.
2020-07-30
Topical montelukast for treatment of atopic dermatitis
Grant 10,548,837 - Avramoff , et al. Fe
2020-02-04
Risperidone microparticles formed by sublimation
Grant 9,107,832 - Lerner , et al. August 18, 2
2015-08-18
Treatment Of Inflammatory Bowel Disease With 6-mercaptopurine
App 20140370105 - Rosenberger; Vered ;   et al.
2014-12-18
Drug Microparticles
App 20140134256 - LERNER; E. Itzhak ;   et al.
2014-05-15
Drug microparticles, processes of preparing them and a drug delivery vehicle comprising them
Grant 8,663,703 - Lerner , et al. March 4, 2
2014-03-04
Treatment Of Inflammatory Bowel Disease With 6-mercaptopurine
App 20130280328 - Rosenberger; Vered ;   et al.
2013-10-24
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
App 20100278912 - Fleshner-Barak; Moshe ;   et al.
2010-11-04
Drug Delivery System For Zero Order, Zero Order Biphasic, Ascending Or Descending Drug Delivery Of Methylphenidate
App 20100151020 - Rosenberger; Vered ;   et al.
2010-06-17
Drug Microparticles
App 20100092568 - Lerner; E. Itzhak ;   et al.
2010-04-15
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
Grant 7,674,480 - Fleshner-Barak , et al. March 9, 2
2010-03-09
Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
Grant 7,611,722 - Lerner , et al. November 3, 2
2009-11-03
Treatment of inflammatory bowel disease with 6-mercaptopurine
App 20090263482 - Rosenberger; Vered ;   et al.
2009-10-22
Levodopa compositions
App 20070178149 - Flashner-Barak; Moshe ;   et al.
2007-08-02
Pharmaceutical formulations of fenofibrate having improved bioavailability
App 20070148233 - Lerner; E. Itzhak ;   et al.
2007-06-28
Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
Grant 7,195,778 - Fleshner-Barak , et al. March 27, 2
2007-03-27
Formulations of fenofibrate containing menthol
App 20070015833 - Flashner-Barak; Moshe ;   et al.
2007-01-18
Formulations of fenofibrate containing PEG/Poloxamer
App 20070015834 - Flashner-Barak; Moshe ;   et al.
2007-01-18
Controlled release dosage forms
App 20060233880 - Lerner; E. Itzhak ;   et al.
2006-10-19
Controlled released dosage forms
App 20060233879 - Lerner; E. Itzhak ;   et al.
2006-10-19
Formulations of fenofibrate
App 20060222707 - Lerner; E. Itzhak ;   et al.
2006-10-05
Dosage forms with an enterically coated core tablet
App 20060153918 - Lerner; E. Itzhak ;   et al.
2006-07-13
Drug microparticles
App 20060141051 - Lerner; E. Itzhak ;   et al.
2006-06-29
Cyclosporin formulations
App 20060141028 - Flashner-Barak; Moshe ;   et al.
2006-06-29
Drug microparticles
App 20060141052 - Lerner; E. Itzhak ;   et al.
2006-06-29
Drug microparticles
App 20060141050 - Lerner; Itzhak E. ;   et al.
2006-06-29
Pharmaceutical dosage forms including rasagiline
App 20060018957 - Lerner; E. Itzhak ;   et al.
2006-01-26
Simvastatin formulations and methods of making same
App 20050192340 - Flashner-Barak, Moshe ;   et al.
2005-09-01
Nanoparticles for drug delivery
App 20050170004 - Rosenberger, Vered ;   et al.
2005-08-04
Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
App 20050112202 - Lerner, E. Itzhak ;   et al.
2005-05-26
Composition and dosage form for sustained effect of levodopa
App 20050113452 - Flashner-Barak, Moshe ;   et al.
2005-05-26
Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
Grant 6,881,420 - Flashner-Barak , et al. April 19, 2
2005-04-19
Compositions and dosage forms for gasteric delivery of antineoplastic agents and methods of treatment that use them to inhibit cancer cell proliferation
App 20050048086 - Flashner-Barak, Moshe ;   et al.
2005-03-03
Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
App 20050026871 - Flashner-Barak, Moshe ;   et al.
2005-02-03
Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
App 20040234608 - Fleshner-Barak, Moshe ;   et al.
2004-11-25
Menthol solutions of drugs
App 20040198646 - Flashner-Barak, Moshe ;   et al.
2004-10-07
Pharmaceutical compositions and dosage forms for buccal and sublingual delivery of tizanidine and methods of administering tizanidine sublingually or buccally
App 20040122065 - Lerner, E. Itzhak ;   et al.
2004-06-24
Controlled release dosage forms
App 20040052843 - Lerner, E. Itzhak ;   et al.
2004-03-18
Drug microparticles
App 20030224059 - Lerner, E. Itzhak ;   et al.
2003-12-04
Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tooling for producing it
App 20030206954 - Lerner, E. Itzhak ;   et al.
2003-11-06
Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
App 20030203878 - Flashner-Barak, Moshe ;   et al.
2003-10-30
Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
App 20030143257 - Fleshner-Barak, Moshe ;   et al.
2003-07-31
Compositions and dosage forms for gastric delivery of antineoplastic agents and methods of treatment that use them to inhibit cancer cell proliferation
App 20020147208 - Fleshner-Barak, Moshe ;   et al.
2002-10-10
Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
App 20020015733 - Flashner-Barak, Moshe ;   et al.
2002-02-07
Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
App 20010024657 - Lerner, E. Itzhak ;   et al.
2001-09-27
Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
Grant 6,197,331 - Lerner , et al. March 6, 2
2001-03-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed